BOSTON SCIENTIFIC ($BSX) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $0.75 per share, beating estimates of $0.68 by $0.07. The company also reported revenue of $4,663,000,000, beating estimates of $4,617,408,697 by $45,591,303.
You can see Quiver Quantitative's $BSX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BOSTON SCIENTIFIC Insider Trading Activity
BOSTON SCIENTIFIC insiders have traded $BSX stock on the open market 31 times in the past 6 months. Of those trades, 1 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $BSX stock by insiders over the last 6 months:
- MICHAEL F MAHONEY (Chairman, President & CEO) has made 0 purchases and 3 sales selling 327,220 shares for an estimated $30,239,922.
- DANIEL J. BRENNAN (EVP and CFO) has made 0 purchases and 4 sales selling 99,950 shares for an estimated $10,504,430.
- JOHN BRADLEY SORENSON (EVP, Global Operations) has made 0 purchases and 6 sales selling 50,658 shares for an estimated $4,789,604.
- ARTHUR C BUTCHER (EVP& Grp Pres, MedSurg & APAC) has made 0 purchases and 3 sales selling 31,323 shares for an estimated $3,013,171.
- JEFFREY B. MIRVISS (EVP&Pres, Periph Intervent) has made 0 purchases and 4 sales selling 21,895 shares for an estimated $2,294,072.
- EDWARD J LUDWIG has made 0 purchases and 2 sales selling 16,877 shares for an estimated $1,712,717.
- ELLEN M ZANE sold 13,586 shares for an estimated $1,416,133
- WENDY CARRUTHERS (EVP, Human Resources) has made 0 purchases and 2 sales selling 13,966 shares for an estimated $1,222,793.
- EMILY WOODWORTH (SVP, Global Controller and CAO) has made 0 purchases and 2 sales selling 11,223 shares for an estimated $1,120,977.
- VANCE R BROWN (SVP, GC and Corp. Secretary) has made 0 purchases and 2 sales selling 9,652 shares for an estimated $991,694.
- JOSEPH MICHAEL FITZGERALD (EVP & Group Pres, Cardiology) has made 1 purchase buying 50 shares for an estimated $4,514 and 1 sale selling 20 shares for an estimated $1,799.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BOSTON SCIENTIFIC Hedge Fund Activity
We have seen 737 institutional investors add shares of BOSTON SCIENTIFIC stock to their portfolio, and 600 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 10,325,678 shares (+8.0%) to their portfolio in Q4 2024, for an estimated $922,289,558
- CAPITAL WORLD INVESTORS added 6,216,199 shares (+28.7%) to their portfolio in Q4 2024, for an estimated $555,230,894
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 6,007,738 shares (-23.4%) from their portfolio in Q4 2024, for an estimated $536,611,158
- CITADEL ADVISORS LLC removed 4,861,651 shares (-49.6%) from their portfolio in Q4 2024, for an estimated $434,242,667
- WELLINGTON MANAGEMENT GROUP LLP added 3,344,571 shares (+10.2%) to their portfolio in Q4 2024, for an estimated $298,737,081
- FMR LLC removed 2,754,011 shares (-2.0%) from their portfolio in Q4 2024, for an estimated $245,988,262
- LEGAL & GENERAL GROUP PLC removed 2,743,301 shares (-20.3%) from their portfolio in Q4 2024, for an estimated $245,031,645
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BOSTON SCIENTIFIC Government Contracts
We have seen $29,495,438 of award payments to $BSX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- Y90 GLASS MICROSPHERES: $2,032,315
- THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION: $1,200,000
- THERASPHERE Y-90: $963,835
- YTTRIUM-90 GLASS MICROSPHERE: $907,100
- THERASPHERE YTTIRUM-90 (Y-90) GLASS MICROSPHERES: $880,560
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BOSTON SCIENTIFIC Congressional Stock Trading
Members of Congress have traded $BSX stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BSX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 03/17, 02/24.
- REPRESENTATIVE BRUCE WESTERMAN purchased up to $15,000 on 03/03.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 02/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
BOSTON SCIENTIFIC Analyst Ratings
Wall Street analysts have issued reports on $BSX in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Outperform" rating on 04/18/2025
- Needham issued a "Buy" rating on 04/16/2025
- Cowen & Co. issued a "Buy" rating on 02/03/2025
- Piper Sandler issued a "Overweight" rating on 02/03/2025
- Deutsche Bank issued a "Buy" rating on 01/10/2025
- Bernstein issued a "Outperform" rating on 01/08/2025
- Evercore ISI issued a "Outperform" rating on 01/02/2025
To track analyst ratings and price targets for BOSTON SCIENTIFIC, check out Quiver Quantitative's $BSX forecast page.
BOSTON SCIENTIFIC Price Targets
Multiple analysts have issued price targets for $BSX recently. We have seen 3 analysts offer price targets for $BSX in the last 6 months, with a median target of $101.0.
Here are some recent targets:
- Matt O'Brien from Piper Sandler set a target price of $115.0 on 02/03/2025
- Vijay Kumar from Evercore ISI set a target price of $100.0 on 01/02/2025
- Marie Thibault from BTIG set a target price of $101.0 on 12/30/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
